123 related articles for article (PubMed ID: 28674227)
1. A systematic analysis of the association studies between CASP8 D302H polymorphisms and breast cancer risk.
Zhang Y; Li W; Hong Y; Wu G; He K; Liu D
J Genet; 2017 Jun; 96(2):283-289. PubMed ID: 28674227
[TBL] [Abstract][Full Text] [Related]
2. Association of two CASP8 polymorphisms with breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Feb; 120(1):229-34. PubMed ID: 19629679
[TBL] [Abstract][Full Text] [Related]
3. The relationship of CASP 8 polymorphism and cancer susceptibility: a meta-analysis.
Ji GH; Li M; Cui Y; Wang JF
Cell Mol Biol (Noisy-le-grand); 2014 Dec; 60(6):20-8. PubMed ID: 25553350
[TBL] [Abstract][Full Text] [Related]
4. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Engel C; Versmold B; Wappenschmidt B; Simard J; Easton DF; Peock S; Cook M; Oliver C; Frost D; Mayes R; Evans DG; Eeles R; Paterson J; Brewer C; ; McGuffog L; Antoniou AC; Stoppa-Lyonnet D; Sinilnikova OM; Barjhoux L; Frenay M; Michel C; Leroux D; Dreyfus H; Toulas C; Gladieff L; Uhrhammer N; Bignon YJ; Meindl A; Arnold N; Varon-Mateeva R; Niederacher D; Preisler-Adams S; Kast K; Deissler H; Sutter C; Gadzicki D; Chenevix-Trench G; Spurdle AB; Chen X; Beesley J; ; Olsson H; Kristoffersson U; Ehrencrona H; Liljegren A; ; van der Luijt RB; van Os TA; van Leeuwen FE; ; Domchek SM; Rebbeck TR; Nathanson KL; Osorio A; Ramón y Cajal T; Konstantopoulou I; Benítez J; Friedman E; Kaufman B; Laitman Y; Mai PL; Greene MH; Nevanlinna H; Aittomäki K; Szabo CI; Caldes T; Couch FJ; Andrulis IL; Godwin AK; Hamann U; Schmutzler RK;
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2859-68. PubMed ID: 20978178
[TBL] [Abstract][Full Text] [Related]
5. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
[TBL] [Abstract][Full Text] [Related]
6. CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers.
Palanca Suela S; Esteban Cardeñosa E; Barragán González E; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Montalar Salcedo J; Castel Sánchez V; Bolufer Gilabert P;
Breast Cancer Res Treat; 2010 Jan; 119(1):87-93. PubMed ID: 19214744
[TBL] [Abstract][Full Text] [Related]
7. Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.
Zhang CD; Li HT; Liu K; Lin ZD; Peng QL; Qin X; He M; Wu H; Mo ZN; Yang XL
Asian Pac J Cancer Prev; 2014; 15(18):7713-8. PubMed ID: 25292051
[TBL] [Abstract][Full Text] [Related]
8. Analysis of CASP8 D302H Gene Variants in Patients with Primary Brain Tumors.
Cacina C; Pence S; Turan S; Genc F; Ozdemir H; Kafadar A; Kaynar MY; Yaylim I
In Vivo; 2015; 29(5):601-4. PubMed ID: 26359420
[TBL] [Abstract][Full Text] [Related]
9. The common D302H variant of CASP8 is associated with risk of glioma.
Bethke L; Sullivan K; Webb E; Murray A; Schoemaker M; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Swerdlow A; Houlston R
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):987-9. PubMed ID: 18398042
[TBL] [Abstract][Full Text] [Related]
10. CASP8 variants D302H and -652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population.
Pittman AM; Broderick P; Sullivan K; Fielding S; Webb E; Penegar S; Tomlinson I; Houlston RS
Br J Cancer; 2008 Apr; 98(8):1434-6. PubMed ID: 18362937
[TBL] [Abstract][Full Text] [Related]
11. Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis.
Hashemi M; Aftabi S; Moazeni-Roodi A; Sarani H; Wiechec E; Ghavami S
Eur J Pharmacol; 2020 Aug; 881():173201. PubMed ID: 32442541
[TBL] [Abstract][Full Text] [Related]
12. A common coding variant in CASP8 is associated with breast cancer risk.
Cox A; Dunning AM; Garcia-Closas M; Balasubramanian S; Reed MW; Pooley KA; Scollen S; Baynes C; Ponder BA; Chanock S; Lissowska J; Brinton L; Peplonska B; Southey MC; Hopper JL; McCredie MR; Giles GG; Fletcher O; Johnson N; dos Santos Silva I; Gibson L; Bojesen SE; Nordestgaard BG; Axelsson CK; Torres D; Hamann U; Justenhoven C; Brauch H; Chang-Claude J; Kropp S; Risch A; Wang-Gohrke S; Schürmann P; Bogdanova N; Dörk T; Fagerholm R; Aaltonen K; Blomqvist C; Nevanlinna H; Seal S; Renwick A; Stratton MR; Rahman N; Sangrajrang S; Hughes D; Odefrey F; Brennan P; Spurdle AB; Chenevix-Trench G; ; Beesley J; Mannermaa A; Hartikainen J; Kataja V; Kosma VM; Couch FJ; Olson JE; Goode EL; Broeks A; Schmidt MK; Hogervorst FB; Van't Veer LJ; Kang D; Yoo KY; Noh DY; Ahn SH; Wedrén S; Hall P; Low YL; Liu J; Milne RL; Ribas G; Gonzalez-Neira A; Benitez J; Sigurdson AJ; Stredrick DL; Alexander BH; Struewing JP; Pharoah PD; Easton DF;
Nat Genet; 2007 Mar; 39(3):352-8. PubMed ID: 17293864
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
14. CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies.
Yin M; Yan J; Wei S; Wei Q
Carcinogenesis; 2010 May; 31(5):850-7. PubMed ID: 20176653
[TBL] [Abstract][Full Text] [Related]
15. Association of a common variant of the CASP8 gene with reduced risk of breast cancer.
MacPherson G; Healey CS; Teare MD; Balasubramanian SP; Reed MW; Pharoah PD; Ponder BA; Meuth M; Bhattacharyya NP; Cox A
J Natl Cancer Inst; 2004 Dec; 96(24):1866-9. PubMed ID: 15601643
[TBL] [Abstract][Full Text] [Related]
16. A breast cancer risk haplotype in the caspase-8 gene.
Shephard ND; Abo R; Rigas SH; Frank B; Lin WY; Brock IW; Shippen A; Balasubramanian SP; Reed MW; Bartram CR; Meindl A; Schmutzler RK; Engel C; Burwinkel B; Cannon-Albright LA; Allen-Brady K; Camp NJ; Cox A
Cancer Res; 2009 Apr; 69(7):2724-8. PubMed ID: 19318553
[TBL] [Abstract][Full Text] [Related]
17. Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers Study.
Park HL; Ziogas A; Chang J; Desai B; Bessonova L; Garner C; Lee E; Neuhausen SL; Wang SS; Ma H; Clague J; Reynolds P; Lacey JV; Bernstein L; Anton-Culver H
BMC Cancer; 2016 Jan; 16():14. PubMed ID: 26758508
[TBL] [Abstract][Full Text] [Related]
18. CAS P8 -652 6N del polymorphism and breast cancer risk: a systematic review and meta-analysis.
Li Z; Wang J; Wang F; Ma Z; Yu Z
Neth J Med; 2014 Jan; 72(1):10-6. PubMed ID: 24457433
[TBL] [Abstract][Full Text] [Related]
19. CASP8 D302H and meningioma risk: an analysis of five case-control series.
Bethke L; Sullivan K; Webb E; Murray A; Schoemaker M; Auvinen A; Kiuru A; Salminen T; Johansen C; Christensen HC; Muir K; McKinney P; Hepworth S; Dimitropoulou P; Lophatananon A; Feychting M; Lönn S; Ahlbom A; Malmer B; Henriksson R; Swerdlow A; Houlston R
Cancer Lett; 2009 Jan; 273(2):312-5. PubMed ID: 18823701
[TBL] [Abstract][Full Text] [Related]
20. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
